SecBot SecBot
8-K/A ·Filed Nov 19, 2026

ICCC

IMMUCELL CORP /DE/
BULLISH
Impact 5/10
Horizonweeks Processed2d 15h ago SEC0001437749-26-037731
8-K with no item list reported
Actionable Insight ▲ Bullish

The strong Q3 beat and termination of the ATM offering remove a near-term overhang. Monitor the Q4 2026 signing of the new $3M credit line and any guidance updates in the next 10-Q.

DirectionBullish
Confidencehigh
Horizonweeks

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

ImmuCell filed an 8-K/A to fix a broken hyperlink in its original 8-K earnings release. The underlying Q3 2026 results show product sales up 46% to $8.0M, net income of $953K vs a loss of $140K a year ago, and the termination of the At-The-Market offering. The amendment itself is purely administrative with no new financial information.

Key Facts

  • Q3 2026 product sales rose 46.0% to $8.0M from $5.5M in Q3 2025
  • Net income was $953K ($0.10/diluted share) vs a net loss of $140K ($0.02 loss per basic share) in Q3 2025
  • Gross margin improved to 44.2% from 42.9%
  • Adjusted EBITDA was $1.9M vs $0.8M in Q3 2025
  • Cash and cash equivalents increased to $7.9M from $3.8M at Dec 31, 2025
  • Company terminated its At-The-Market offering and negotiated a new $3M line of credit expected to close in Q4 2026
  • The 8-K/A only fixes a broken hyperlink in the original 8-K; no financial changes

Financial Impact

Revenue up 46% YoY to $8.0M; net income swing of +$1.1M to $953K; cash balance doubled to $7.9M

revenuenet incomegross margincash

Risk Factors

  • Revenue growth was aided by absence of prior-year distributor destocking headwinds, which may not repeat
  • Sales, marketing and administrative expenses grew 47% YoY, outpacing gross profit growth in absolute dollars
  • Small-cap stock with limited liquidity and $103M market cap

Market Snapshot

Exchange
Nasdaq
Sector
In Vitro & In Vivo Diagnostic Substances
Analyst Consensus
86% bullish (7 analysts)

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K/A Filing (Primary)0001437749-26-037731
Document: iccc20261118_8ka.htm0001437749-26-037731
Document: 0001437749-26-037731-index-headers.html0001437749-26-037731
Document: 0001437749-26-037731-index.html0001437749-26-037731
Document: 0001437749-26-037731.txt0001437749-26-037731

Track record

8 reports on ICCC

Performance horizon

2 of 3 bullish or bearish reports moved the stock their way by T+5. Best: +27.22% at T+60 after the May 8, 2026 report. 2 of 3 went positive at some point.

Filters
  1. Nov 19, 20262d ago 8-K/A Bullish 5/10 Viewing Entry $11.27 Now $10.92 −3.13% settles Nov 30
  2. Nov 12, 20269d ago Press Release Bullish 5/10 Entry $10.75 to $10.92 Now $10.92 +1.58% ▲ +1.58% +10.14% vs SPY
  3. Oct 13, 20265w ago 8-K Bullish 6/10 Entry $10.79 to $10.45 Now $10.92 +1.20% ▼ −3.15% −2.00% vs SPY
  4. May 8, 202628w ago 8-K Bullish 4/10 Entry $8.45 to $9.91 Now $10.92 +29.23% ▲ +17.28% +17.36% vs SPY
  5. Apr 8, 202632w ago 8-K Bullish 7/10 No price data
  6. Apr 8, 202632w ago Press Release Mixed 6/10 Entry $7.19 to $7.54 Now $10.92 +51.88% ▲ +4.87% +1.68% vs SPY
  7. Mar 4, 202637w ago 8-K Mixed 6/10 Entry $6.35 to $6.63 Now $10.92 +71.97% ▲ +4.41% +6.65% vs SPY
  8. Mar 4, 202637w ago Press Release Mixed 6/10 Entry $6.35 to $6.63 Now $10.92 +71.97% ▲ +4.41% +6.65% vs SPY
Showing 8 of 8

US Market Status

Market Closed · Opens Mon (26h 12m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 19, 2026